Incyte’s $750 Million Acquisition of Escient Pharmaceuticals

Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte.Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte will…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now